Alkem Laboratories rises as USFDA concludes inspection at its Bioequivalence Center at Taloja

30 Jul 2021 Evaluate

Alkem Laboratories is currently trading at Rs. 3372.40, up by 40.95 points or 1.23% from its previous closing of Rs. 3331.45 on the BSE.

The scrip opened at Rs. 3355.00 and has touched a high and low of Rs. 3379.50 and Rs. 3327.10 respectively. So far 349 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 3603.30 on 16-Jul-2021 and a 52 week low of Rs. 2505.00 on 30-Jul-2020.

Last one week high and low of the scrip stood at Rs. 3498.00 and Rs. 3302.95 respectively. The current market cap of the company is Rs. 39832.48 crore.

The promoters holding in the company stood at 58.84%, while Institutions and Non-Institutions held 18.99% and 22.17% respectively.

The United States Food and Drug Administration (USFDA) had conducted a remote and virtual Bio-Analytical inspection of Alkem Laboratories’ Bioequivalence Center located at Taloja, Maharashtra from July 26, 2021 to July 28, 2021. At the end of the inspection, no Form 483 was issued.

Alkem Laboratories is a leading Indian pharmaceutical company with global operations, engaged in the development, manufacture and sale of pharmaceutical and nutraceutical products. The company produces branded generics, generic drugs, active pharmaceutical Ingredients (APIs) and nutraceuticals, which it markets in India and International markets.

Alkem Laboratories Share Price

5409.65 -69.80 (-1.27%)
24-Dec-2024 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1817.60
Dr. Reddys Lab 1351.25
Cipla 1475.90
Lupin 2168.30
Zydus Lifesciences 964.40
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.